Risk stratification and medical therapy of pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. The recent progress observed in medical therapy of PAH is not, therefore, related to the discovery of new pathways, but to the development of new strategies for combination therapy and on escalation of treatments based on systematic assessment of clinical response. The current treatment strategy is based on the severity of the newly diagnosed PAH patient as assessed by a multiparametric risk stratification approach. Clinical, exercise, right ventricular function and haemodynamic parameters are combined to define a low-, intermediate- or high-risk status according to the expected 1-year mortality. The current treatment algorithm provides the most appropriate initial strategy, including monotherapy, or double or triple combination therapy. Further treatment escalation is required in case low-risk status is not achieved in planned follow-up assessments. Lung transplantation may be required in most advanced cases on maximal medical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 Time-course of completed randomised controlled trials (RCTs) in pulmonary arterial hypertension (PAH) (n=41) according to treatment strategy. SSc: systemic sclerosis; IPAH: idiopathic PAH. Reproduced and modified from [70] with permission.](https://figures.cochat.ai/paper-figures/44281cb9913845f29b53a42c8e3258e5/risk-stratification-and-medical-therapy-of-pulmonary-arterial-hypertension-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other high-risk profiles include familial PAH, PVOD, CTD-PAH, CTD-PAH associated with concomitant ILD, rapidly progressive disease despite therapy, and development of hemoptysis.(282, 291–293)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In particular, the 2018 World Symposium on Pulmonary Hypertension strongly recommends serial parametric risk assessment.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“The 2018 World Symposium on Pulmonary Hypertension states that the ultimate goal of therapy for patients with PAH is to achieve a low-risk status, assessed either by REVEAL or the ESC/ERS model.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationInhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationBenza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Self-citationChannick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Self-citation
Research works printed but not linked: 2
- Benza, 2018, Comparison of three assessment strategies as predictors of one-year survival in US pulmonary arterial hypertension (PAH) patients, Am J Respir Crit Care Med, 197, A7649
- Galiè, 2014, AMBITION: a randomised, multicenter study of first-line ambrisentan and tadalafil combination therapy in subjects with pulmonary arterial hypertension (PAH), Eur Respir J, 44, 2916
Cited by
Items 401–500 of 897
Management of pulmonary arterial hypertension:before, during and after pregnancy
Teng, Y., Zong, L., Ding, J., Wu, M., & Li, X. (2024) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2024.200252 · Cited by 8
(18)F‐fluorodeoxyglucose uptake by positron emission tomography in patients with IPAH and CTEPH
Sümer, Ç., Okumuş, G., Işık, E. G., Türkmen, C., Bilge, A. K., & İnanç, M. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12363 · Cited by 8
Yuan, Y., Li, S., Yan, M., Yang, Y., Zhong, C., & Hu, Y. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02877-2 · Cited by 8
Jiang, L., Tao, W., Liu, J. L., Yang, A., & Zhou, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-79769-2 · Cited by 8
Jose, A., Yogeswaran, A., Fünderich, M., Kiely, D. G., Sweatt, A. J., Zamanian, R. T., Hassoun, P. M., Mouawad, A., Balasubramanian, A., Wilkins, M. R., et al. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70121 · Cited by 8
Self-citationImpact of the updated hemodynamic definitions on diagnosis rates of pulmonary hypertension
Tanyeri, S., Akbal, Ö. Y., Keskin, B., Hakgör, A., Karagöz, A., Tokgöz, H. C., Doğan, C., Bayram, Z., Külahçıoğlu, Ş., Erdoğan, E., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020931299 · Cited by 8
Zhao, J., Wang, Q., Wang, Q., Zhang, Y., Zhang, N., Zhang, R., Hao, Y., Jia, J., Li, M., & Zeng, X. (2021) · Rheumatology and Immunology Research · doi:10.2478/rir-2021-0010 · Cited by 8
Tielemans, B., Stoian, L., Wagenaar, A., Leys, M., Belge, C., Delcroix, M., & Quarck, R. A. (2021) · Cells · doi:10.3390/cells10113229 · Cited by 8
Kimuro, K., Hosokawa, K., Abe, K., Masaki, K., Imakiire, S., Sakamoto, T., & Tsutsui, H. (2022) · Life · doi:10.3390/life12060780 · Cited by 8
Sargent, T., Tsang, Y., Panjabi, S. S., Funtanilla, V., Germack, H. D., Gauthier‐Loiselle, M., Manceur, A. M., Cloutier, M., & Lefèbvre, P. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02658-z · Cited by 8
Zheng, Q., Zhang, B., Lu, N., Li, X., Jin, B., & Jin, P. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.986 · Cited by 8
Kiely, D. G., Hamilton, N., Wood, S., Durrington, C., Exposto, F., Muzwidzwa, R., Raiteri, L., Beaudet, A., Muller, A., Sauter, R., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080068 · Cited by 8
Inhaled iloprost as third add‐on therapy in idiopathic pulmonary arterial hypertension
Fernandes, C. J. C. D. S., da Silva, T. A. F., Alves, J. L., Jardim, C., & Souza, R. (2020) · Pulmonary Circulation · doi:10.1177/2045894020981350 · Cited by 8
Meñaca, A. M., Vich, I. B., López‐Meseguer, M., Reyes, R. L., Díaz, P. B., Elías-Hernández, T., Peñafiel, I. F.-C., Fernández, G., Liste, A. Á., & Subías, P. E. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01625-w · Cited by 8
Ţilea, I., Varga, A., Georgescu, A. M., & Grigorescu, B.-L. (2021) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2021-0020 · Cited by 8
Shang, Z., Sun, J., Hui, J., Yu, Y., Bian, X., Yang, B., Deng, K., & Li, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.781011 · Cited by 8
Forfia, P. R., Benza, R. L., D’Alto, M., Marco, T. D., Elwing, J., Frantz, R. P., Haddad, F., Oudiz, R. J., Preston, I. R., Rosenkranz, S., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12240 · Cited by 8
Self-citationManagement of Pulmonary Arterial Hypertension
Weatherald, J. C., Varughese, R. A., Liu, J., & Humbert, M. J. C. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1770118 · Cited by 8
da Silva, M. D. M. C., Alencar, A. K. N., da Silva, J. S., Montagnoli, T. L., da Silva, G. F., Rocha, B., Montes, G. C., Méndez‐Otero, R., Pimentel‐Coelho, P. M., Vasques, J. F., et al. (2020) · Cells · doi:10.3390/cells9092120 · Cited by 8
Alotaibi, M., Harvey, L. D., Nichols, W. C., Pauciulo, M. W., Hemnes, A. R., Long, T., Watrous, J. D., Begzati, A., Tuomilehto, J. O., Havulinna, A. S., et al. (2026) · American Journal of Respiratory and Critical Care Medicine · doi:10.1093/ajrccm/aamag383 · Cited by 8
Siniarski, A., Gąsecka, A., Starczyński, M., Banaszkiewicz, M., Darocha, S., Torbicki, A., Kurzyna, M., Filipiak, K. J., Nessler, J., & Gajos, G. (2022) · Platelets · doi:10.1080/09537104.2022.2042234 · Cited by 7
Real-world evidence of subcutaneous treprostinil use in pulmonary arterial hypertension in Argentina
Lescano, A. J., Giacomi, G., Botta, C. E., Soricetti, J., Rodriguez, M., Mieles, P. V., & Diez, F. (2022) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666221132735 · Cited by 7
Zhang, M., Xie, W., Xiao, Y., Guo, W., Wang, Y., Zhang, W., Duan, S., Gao, Q., Zhang, S., Zhang, Y., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12241 · Cited by 7
Villegas-Esguevillas, M., Cho, S., Vera‐Zambrano, A., Kwon, J. W., Barreira, B., Telli, G., Navarro‐Dorado, J., Morales‐Cano, D., de Olaiz, B., Moreno, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114952 · Cited by 7
Deriving Convergent and Divergent Metabolomic Correlates of Pulmonary Arterial Hypertension
Alotaibi, M., Liu, Y., Magalang, G. A., Kwan, A. C., Ebinger, J. E., Nichols, W. C., Pauciulo, M. W., Jain, M., & Cheng, S. C. (2023) · Metabolites · doi:10.3390/metabo13070802 · Cited by 7
Zheng, Y., Yuan, P., Zhang, Z., Fu, Y., Li, S., Ruan, Y., Li, P.-Y., Chen, Y., Feng, W., & Zheng, X. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s436866 · Cited by 7
Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH
Escal, J., Poénou, G., Delavenne, X., Bezzeghoud, S., Mismetti, V., Humbert, M. J. C., Montani, D., & Bertoletti, L. (2024) · Blood Reviews · doi:10.1016/j.blre.2024.101240 · Cited by 7
He, J., & Liao, J. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70068 · Cited by 7
Allison, J. D., Zehner, C. A., Jia, X., Hamzeh, I., Alam, M., Nair, A. P., & Birnbaum, Y. (2020) · Cardiology · doi:10.1159/000510348 · Cited by 7
Norell, P. N., Ivarsson, B., Selin, M., & Kjellström, B. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12114 · Cited by 7
Kaymaz, C., Tanyeri, S., Tokgöz, H. C., Akbal, Ö. Y., Karagöz, A., Keskin, B., Kültürsay, B., Hakgör, A., Külahçıoğlu, Ş., Bayram, Z., et al. (2022) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2022.1889 · Cited by 7
Li, J., Li, A., Zhai, Y., Li, L., Zhang, Y., Chen, A., Tao, X., Gao, Q., Xie, W., & Zhai, Z. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02207-4 · Cited by 7
Gong, C., Guo, J., Wan, K., Wang, L., Chen, X., Guo, J., He, J., Yin, L., Wen, B., Pu, S., et al. (2022) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-022-00880-2 · Cited by 7
Cardiopulmonary Exercise Test and Rehabilitation for Pulmonary Hypertension Patients.
Chiu, Y., & Huang, W. (2022) · PubMed · doi:10.6515/acs.202211_38(6).20220603a · Cited by 7
Crossman, L. M., Rajaram, P., Hart, C. M., Pernetz, M. A., Sahu, A., Jokhadar, M., Book, W., Fisher, M. R., & Trammell, A. W. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12204 · Cited by 7
del Valle, K. T., & DuBrock, H. M. (2022) · Comprehensive physiology · doi:10.1002/j.2040-4603.2022.tb00212.x · Cited by 7
Jose, A., Kher, A., O’Donnell, R. E., & Elwing, J. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.108784 · Cited by 7
Mularek‐Kubzdela, T., Ciurzyński, M., Kowal‐Bielecka, O., Kasprzak, J. D., Kopeć, G., Mizia‐Stec, K., Mroczek, E., Lewicka, E., Skoczylas, I., Grabka, M., et al. (2021) · Kardiologia Polska · doi:10.33963/kp.a2021.0055 · Cited by 7
Advanced Circulatory Support and Lung Transplantation in Pulmonary Hypertension
Budev, M. M., & Yun, J. J. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.09.001 · Cited by 7
Update on Medical Management of Pulmonary Arterial Hypertension
Sherman, A. E., Saggar, R., & Channick, R. N. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.08.002 · Cited by 7
Self-citationTamura, Y., Furukawa, A., Tamura, Y., Yamada, K., Taniguchi, H., Fukuda, K., Kawamura, A., & Satoh, T. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12058 · Cited by 7
Self-citationSong, C., Kunovszki, P., & Beaudet, A. (2022) · Journal of health economics and outcomes research · doi:10.36469/001c.35246 · Cited by 7
Managing pulmonary arterial hypertension: how to select and facilitate successful transplantation
Khangoora, V. S., King, C. S., & Shlobin, O. A. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000980 · Cited by 7
Manzi, G., Papa, S., Mariani, M. V., Scoccia, G., Filomena, D., Malerba, C., Adamo, F. I., Caputo, A., Lazzari, C. D., Lazzari, B. D., et al. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107024 · Cited by 7
Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside
Mazzola, M., Madonna, R., Badagliacca, R., & Caterina, R. D. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107022 · Cited by 7
Pulmonary Hypertension in Scleroderma– Evaluation and Management
Chennakesavulu, P. V., Uppaluri, S., Koyi, J., Jhaveri, S., Avanthika, C., Sakhamuri, L. T., Ashokbhai, P. K., & Singh, P. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101468 · Cited by 7
Degering, J., Egenlauf, B., Harutyunova, S., Benjamin, N., Salkić, A., Xanthouli, P., Eichstaedt, C. A., Seeger, R., Sitbon, O., & Grünig, E. (2023) · Respiratory Research · doi:10.1186/s12931-022-02296-z · Cited by 7
Self-citationValidity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
Gong, S., Wu, W., Li, C., Zhao, Q., Jiang, R., Luo, C., Qiu, H., Liu, J., Wang, L., & Zhang, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.745578 · Cited by 7
Vraka, A., Yerly, P., & Aubert, J. (2022) · Respiration · doi:10.1159/000520886 · Cited by 7
Diez años de experiencia de un centro de referencia en hipertensión arterial pulmonar en Uruguay
Gruss, A., Pascal, G., Chao, C., Janssen, B., Bedó, C., Salisbury, J. P., Trujillo, P., Curbelo, P., & Grignola, J. C. (2019) · Revista Médica del Uruguay · doi:10.29193/rmu.35.3.3 · Cited by 7
Let’s Talk about Sex: Sexual Health in Pulmonary Arterial Hypertension
Al‐Naamani, N. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202204-322ed · Cited by 7
Schütz, N., Glinskii, V. V., Anderson, R. J., del Rosario, P. A., Hedlin, H., Lee, J., Hess, J., Wormer, S. V., Lopez, A., Hershman, S. G., et al. (2024) · medRxiv · doi:10.1101/2024.08.08.24311687 · Cited by 7
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
Coons, J. C., & Empey, P. E. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s361222 · Cited by 6
Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling
Fang, Q., Bai, Y., Hu, S., Ding, J., Liu, L., Dai, M., Qiu, J., Wu, L., Rao, X., & Wang, Y. (2023) · Antioxidants · doi:10.3390/antiox12111978 · Cited by 6
Morland, K., Gerges, C., Elwing, J., Visovatti, S., Weatherald, J. C., Gillmeyer, K. R., Sahay, S., Mathai, S. C., Boucly, A., Williams, P., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12317 · Cited by 6
Self-citationBenza, R. L., Simonneau, G., Ghofrani, H. A., Corris, P. A., Langleben, D., Rosenkranz, S., White, R. J., Cheng, C.-C., Campos, F. T. A. F., Kim, H., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.06.002 · Cited by 6
Melendres-Groves, L. D., Tang, W., Germack, H. D., Liu, Z., & Sadik, K. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2377682 · Cited by 6
Yu, L., Jiang, D., Wang, X., Fang, Z., Chen, W., Zhao, J., Yi, X., & Liu, W. (2025) · Current Medical Science · doi:10.1007/s11596-025-00108-1 · Cited by 6
Li, Z., Li, H., Qiao, W., Yu, S., Fan, B., Yang, M., Zhou, L., Qiu, F., Wu, Z., & Wang, J. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003601 · Cited by 6
Mou, H., Zhang, G., Xiu, L., Zhao, Q., Zhang, R., & Liu, G.-A. (2026) · Scientific Reports · doi:10.1038/s41598-026-36533-y · Cited by 6
Sun, Y., Wang, L., Meng, X., Gong, S., Zhao, Q., Shi, L., Jiang, R., He, J., Wu, W., Li, Y., et al. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-2732 · Cited by 6
Transplantation pulmonaire en France : actualisation des indications et contre-indications en 2022
Pavec, J. L., Pison, C. M., Hirschi, S., Bunel, V., Mordant, P., Brugière, O., Guen, M. L., Olland, A., Coiffard, B., Renaud-Picard, B., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.10.005 · Cited by 6
Effects of COVID-19 pandemic on the management of pulmonary hypertension
Zhou, C. Y., Sahay, S., Shlobin, O. A., Soto, F. J., Mathai, S. C., Melendres-Groves, L. D., Mullin, C. J., Levine, D. J., Kay, D., Highland, K. B., et al. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.107061 · Cited by 6
Peng, Y., Dai, J., & Zhao, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032391 · Cited by 6
Zhang, X., Zhai, Z., Xu, G., Zhu, Y., Yang, S., Chen, T., Wu, X., Zhang, J., Guo, Z.-G., & Hou, M. (2023) · Computational and Mathematical Methods in Medicine · doi:10.1155/2023/1896026 · Cited by 6
Sonnweber, T., Tymoszuk, P., Steringer‐Mascherbauer, R., Sigmund, E., Porod-Schneiderbauer, S., Kohlbacher, L., Theurl, I., Lang, I. M., Weiß, G., & Löffler‐Ragg, J. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02427-2 · Cited by 6
Pradère, P., Pavec, J. L., Bos, S., Pozza, A., Nair, A., Meachery, G. J., Lordan, J. L., Humbert, M. J. C., Mercier, O. M., Fadel, É., et al. (2024) · ERJ Open Research · doi:10.1183/23120541.00521-2023 · Cited by 6
Dörr, O., Keranov, S., van Wickern, P., NEF, H. M., Hamm, C. W., Bauer, P., Troidl, C., Sossalla, S. T., Voss, S., Liebetrau, C., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15159 · Cited by 6
Wahab, R., Keshavarz, A. A., Azam, Z., Islam, T., Hasan, M. M., Zhang, X., Alobaida, A., Rana, M., Choi, J. U., Alam, F., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123429 · Cited by 6
Coronel, M. L., Díez, M., Lema, L. R., Lescano, A. J., Moris, M. C., Sorasio, G., Echazarreta, D. F., Vulcano, N. O., Murga, A. F., Caruso, N. A., et al. (2022) · Revista de la Federación Argentina de Cardiología · doi:10.63600/c8263c02 · Cited by 6
Kimmig, L. M., Liao, C., & Bag, R. (2020) · Lung · doi:10.1007/s00408-019-00306-4 · Cited by 6
Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients
Tahara, N., Dobashi, H., Fukuda, K., Funauchi, M., Hatano, M., Ikeda, S., Joho, S., Kihara, Y., Kondo, T., Matsushita, M., et al. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1756234 · Cited by 6
Gupta, S., Batt, J. A. E., Bourbeau, J., Chapman, K. R., Gershon, A. S., Granton, J. T., Hambly, N., Hernandez, P., Kolb, M. R. J., Mehta, S., et al. (2020) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2020.1769436 · Cited by 6
Hung, C. C., Cheng, C.-C., Huang, W., Lin, K.-C., Kuo, F. Y., Kuo, S., Yang, T.-H., Liang, H.-L., & Mar, G.-Y. (2020) · PubMed · doi:10.6515/acs.202011_36(6).20200507a · Cited by 6
Hatano, M., Abe, K., Koike, G., Takahashi, T., Tunmer, G., & Kiely, D. G. (2022) · International Heart Journal · doi:10.1536/ihj.21-497 · Cited by 6
Li, M., Tian, Z., Qian, J., Huang, C. L., Zhao, J., Wang, Q., Song, Y., Tian, X., Li, M., Liu, J., et al. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2021-000636 · Cited by 6
Gauthier‐Loiselle, M., Tsang, Y., Lefèbvre, P., Agron, P., Royer, J., Lynum, K. S. B., Bennett, L., & Panjabi, S. S. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2049162 · Cited by 6
Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
Moles, V., & Grafton, G. F. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.06.007 · Cited by 6
Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension
Zhang, C., Tsang, Y., He, J., & Panjabi, S. S. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02501-5 · Cited by 6
Palevičiūtė, E., Čelutkienė, J., Šimbelytė, T., Gumbienė, L., Jurevičienė, E., Zakarkaitė, D., Čėsna, S., Eichstaedt, C. A., Benjamin, N., & Grünig, E. (2023) · Trials · doi:10.1186/s13063-023-07297-x · Cited by 6
Self-citationReversible pulmonary hypertension associated with multivisceral Whipple's disease
Camboulive, A., Jutant, E., Savale, L., Jaïs, X., Sitbon, O., Mussini, C., Bénichou, J., Lagier, J., Humbert, M. J. C., & Montani, D. (2020) · European Respiratory Journal · doi:10.1183/13993003.03132-2020 · Cited by 6
Rezende, C. F., Mancuzo, E. V., Nunes, M. C. P., & Corrêa, R. D. A. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220461 · Cited by 6
Treatment-related biomarkers in pulmonary hypertension patients on oral therapies
Swaminathan, A. C., Zhu, H., Tapson, V. F., Lokhnygina, Y. V., Poms, A. D., Kelleher, Z. T., Gaspard, E., Kennedy, K., Fee, B. E., Fortin, T., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01566-y · Cited by 6
Coons, J. C., Crisamore, K. R., Adams, S. M., Modany, A., Simon, M. A. M., Zhao, W., Shaik, I. H., Venkataramanan, R., & Empey, P. E. (2021) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666211013688 · Cited by 6
Phenotypes of idiopathic pulmonary arterial hypertension – Authors' reply
Hoeper, M. M., Noordegraaf, A. V., & Kiely, D. G. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00273-9 · Cited by 6
American Lung Association Pulmonary Hypertension Roundtable: Executive Summary
Kolaitis, N. A., Sahay, S., Rosenzweig, E. B., Brown, D., Hemnes, A. R., Joseloff, E., Meyer, J., Pescatore, K. A., Rizzo, A., Sood, N., et al. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70200 · Cited by 5
Self-citationMultidimensional study on mitochondrial dysfunction in pulmonary hypertension
Yuan, X.-T., Zhang, Y., Liu, Y., Guo, X., Jia, S., Xiong, X., Xiuying, S., & Jin, Z. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1716485 · Cited by 5
Silic, V., Pavlović, D. B., Džubur, F., Romić, I., Petrović, I., Pavlek, G., Žedelj, J., Redžepi, G., & Samaržija, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm15010072 · Cited by 5
Weiss, T., Ramey, D. R., Yang, L., Liu, X., Patel, M. J., Rajpathak, S. N., Bajwa, E. K., & Lautsch, D. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02167-9 · Cited by 5
Gong, J., Li, H., Cui, X., Yan, Y., Yu, Q., Ding, Q., Shi, Y., & Wang, P. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119395 · Cited by 5
Assessment of the REPLACE study composite endpoint in riociguat‐treated patients in the PATENT study
Simonneau, G., Ghofrani, H. A., Corris, P. A., Rosenkranz, S., Grünig, E., White, R. J., McLaughlin, V. V., Langleben, D., Meier, C., Busse, D., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020973124 · Cited by 5
Self-citationGratsianskaya, S. E., Солтановна, В. З., & Martynyuk, T. V. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.09.000717 · Cited by 5
Pharmacological Interventions for Pulmonary Involvement in Rheumatic Diseases
Kang, E. H., & Song, Y. W. (2021) · Pharmaceuticals · doi:10.3390/ph14030251 · Cited by 5
A Simplified Diagnostic and Therapeutic Approach to Pulmonary Hypertension
Gupta, T., Shariati, F., & Krim, S. R. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100857 · Cited by 5
Martynyuk, T. V., & Chazova, I. E. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.09.201013 · Cited by 5
Severity of precapillary pulmonary hypertension: Predictive factor
de Barros, J. A., Sant’Ana, G., Martins, G., Madlum, L., Scremim, C. F., Petterle, R. R., Escuissato, D. L., & Júnior, E. L. (2021) · Pulmonology · doi:10.1016/j.pulmoe.2021.11.007 · Cited by 5
Lawrie, A., Hamilton, N., Wood, S., Exposto, F., Muzwidzwa, R., Raiteri, L., Beaudet, A., Muller, A., Sauter, R., Pillai, N., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12136 · Cited by 5
Omura, J., Makanji, Y., Tanabe, N., Yu, D. Y., Tan, J. Y., Lim, S., Kouhkamari, M. H., Casorso, J., Wu, D. B.-C., & Bloomfield, P. (2023) · Pulmonary Therapy · doi:10.1007/s41030-023-00244-w · Cited by 5
Partitioning Mechanical Ventilator Duration in COVID-19–related Acute Respiratory Distress Syndrome
Gendreau, S., Benelli, B., Delière, M., Tuffet, S., de Prost, N., Razazi, K., Carteaux, G., & Dessap, A. M. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1963le · Cited by 5
Sharma, D., Shah, R. J., Sreenivasan, J., Kafle, P., Gupta, R., Levine, A., Lanier, G. M., & Aronow, W. S. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2092095 · Cited by 5
Metadata
- Authors
- Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., & McLaughlin, V. V.
- Affiliations
- University of Bologna (IT)
- Harvard University (US)
- Mayo Clinic (US)
- University Hospital Heidelberg (DE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Tufts University (US)
- Houston Methodist (US)
- International University of Health and Welfare (JP)
- University of Michigan (US)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801889
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351343
- OpenAlex
- W2904385559
- Cited by
- 819
- References
- 88
- Citations by year
- 2026: 32 · 2025: 46 · 2024: 101 · 2023: 108 · 2022: 174 · 2021: 169 · 2020: 128 · 2019: 58
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (18K08183)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- pulmonary arterial hypertension, risk stratification, medical therapy, combination therapy, treatment escalation, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostacyclin analogues, right ventricular function, exercise capacity, one-year mortality, lung transplantation, treatment algorithm
- MeSH terms
- Pulmonary Arterial Hypertension, Calcium Channel Blockers, Humans, Randomized Controlled Trials as Topic, Lung Transplantation, Practice Guidelines as Topic, Risk Assessment, Phosphodiesterase 5 Inhibitors, Endothelin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.